Flow Cytometry of Hematological Malignancies

XX ZAP-70 Protein, XX 2 DISEASES Myeloproliferative neoplasms, XXX Chronic myeloid leukemia (CML), XXX Myeloproliferative neoplasms other than CML, XXX Chronic neutrophilic leukemia (CNL), XXX Polycythemia vera (PV), XXX Primary myelofibrosis (PMF), XXX Essential thrombocythemia (ET), XXX Chronic eosinophilic leukemia (CEL), XXX Mastocytosis, XXX Acute masT-cell leukemia (AMCL), XXX Chronic masT-cell leukemia (CMCL), XXX Myelomastocytic leukemia (MML), XXX Myelodysplastic/myeloproliferative neoplasms, XXX Chronic myelomonocytic leukemia (CMML), XXX Other myelodysplastic/myeloproliferative neoplasms and related conditions, XXX Juvenile myelomonocytic leukemia (JMML), XXX Atypical CML bcr/abl negative (ACML), XXX RAS-associated autoimmune leukoproliferative disorder (RALD), XXX Myelodysplastic syndromes, XXX Myeloid neoplasms with germline predisposition, XXX Acute myeloid leukemias, XXX AMLs with recurrent genetic anomalies, XXX AMLs with chromosomal anomalies, XXX AMLs with gene mutations, XXX AMLs with recurrent genetic anomalies, not recognized by the WHO classification, XXX AMLs with myelodysplastic related changes (AML-MRC), XXX AMLs not otherwise specified, XXX AML with minimal differentiation, XXX AML without maturation, XXX AML with maturation, XXX Acute myelomonocytic leukemia (AMMoL), XXX Acute monoblastic or monocytic leukemia (AMoL), XXX Pure erythroid leukemia (PEL), XXX Acute megakaryoblastic leukemia (AMKL), XXX Acute basophilic leukemia (ABL), XXX Myeloid proliferations associated with Down syndrome, XXX Transient abnormal myelopoiesis (TAM), XXX AMLs in patients with Down syndrome, XXX Blastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL), XXX Acute leukemias with ambiguous lineage attribution (ALAL), XXX Acute undifferentiated leukemias (AUL), XXX Mixed phenotype acute leukemias (MPAL), XXX Neoplastic diseases of B and T lymphatic precursors, XXX B lymphoblastic leukemia/lymphoma, not otherwise specified (B-ALL/LBLnos), XXX B lymphoblastic leukemia/lymphoma with recurrent genetic anomalies, XXX T lymphoblastic leukemia/lymphoma (T-ALL/LBL), XXX Early T-cell precursors lymphoblastic leukemia (ETP-ALL), XXX NK lymphoblastic leukemia/lymphoma (NK-ALL/LBL), XXX Neoplastic diseases of mature B cells, XXX Chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL), XXX Familial B-CLL, XXX Richter syndrome, XXX Monoclonal B-cell lymphocytosis (MBL), XXX B-cell prolymphocytic leukemia (B-PLL), XXX Lymphoplasmacytic lymphoma (LPL), XXX Heavy chain disease (HCD), XXX Gamma heavy chain disease, XXX Mu heavy chain disease, XXX Alpha heavy chain disease, XXX Hairy cell leukemia (HCL), XXX Hairy cell leukemia, variant (HCL-v), XXX Hairy cell leukemia, Japanese variant (HCL-J), XXX Splenic diffuse red pulp lymphoma (SDRPL), XXX Marginal zone lymphomas (MZL), XXX Nodal marginal zone lymphoma (NMZL), XXX Splenic marginal zone lymphoma (SMZL), XXX Extranodal marginal zone lymphoma (EMZL/MALToma), XXX Clonal B-cell lymphocytosis with MZL-like phenotype (CBL-MZ), XXX Follicular lymphoma (FCL), XXX Testicular follicular lymphoma, XXX Duodenal type follicular lymphoma, XXX Pediatric type follicular lymphoma, XXX Primitive cutaneous follicular lymphoma (PCFL), XXX Large B-cell lymphoma with IRF4 rearrangement, XXX Mantle cell lymphoma (MCL), XXX Blastic mantle cell lymphoma (BMCL), XXX Leukemic non nodal mantle cell lymphoma, XXX Diffuse large B-cell lymphomas (DLBCLs), XXX DLBCL not otherwise specified (DLBCL nos), XXX T-cell/histiocyte-rich B-cell lymphoma (THRLBCL), XXX Primary DLBCL of the CNS (PCNSL), XXX Primary cutaneous DLBCL, "leg type", XXX EBV(+) DLBCL nos, XXX DLBCL associated with chronic inflammation (PAL), XXX Lymphomatoid granulomatosis (LyG), XXX Primary mediastinal B-cell lymphoma (PMBCL), XXX Intravascular large B-cell lymphoma (IVBCL), XXX ALK-positive large cell lymphoma (ALK(+) LBCL), XXX Plasmablastic lymphoma (PBL), XXX Primary effusion lymphoma (PEL), XXX HHV8-associated lymphoproliferative disorders, XXX Burkitt lymphoma (BL), XXX Burkitt leukemia with immature phenotype, XXX Burkitt-like lymphoma with 11q aberrations, XXX High grade B-cell lymphoma (HGBL), XXX Plasma cell neoplasms, XXX Monoclonal gammopathies of undetermined significance (MGUS), XXX Multiple myeloma (MM), XXX Plasma cell leukemia (PCL), XXX Neoplastic diseases of mature T and NK cells, XXX T-cell prolymphocytic leukemia (T-PLL), XXX T-cell large granular lymphocytic leukemia (T-LGL), XXX Chronic lymphoproliferative disorders of NK cells (CLPD-NK/CNKL), XXX Aggressive NK-cell leukemia (ANKL), XXX Adult T-cell leukemia/lymphoma (ATLL), XXX Extranodal NK/T-cell lymphoma, "nasal type" (ENKTL), XXX Intestinal T-cell lymphoma (ITCL), XXX Enteropathy-associated T-cell lymphoma (EATCL), XXX Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL), XXX Indolent gastro-intestinal T lymphoproliferative disorder, XXX Hepatosplenic T-cell lymphoma (HTSCL), XXX Subcutaneous panniculitis-like T-cell lymphoma (SPTCL), XXX Mycosis fungoides (MF), XXX Sézary syndrome (SS), XXX Primary cutaneous CD30(+) lymphoproliferative disorders, XXX Lymphomatoid papulosis (LyP), XXX Primary cutaneous anaplastic T-cell lymphoma (cALCL), XXX Primary cutaneous peripheral T-cell lymphoma (PTCL), XXX Primary cutaneous TCRgammadelta(+) T-cell lymphoma (PCGD-TCL), XXX Primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma, XXX Primary cutaneous acral CD8(+) T-cell lymphoma Primary cutaneous lymphoma of the medium/small CD4(+) T cells (PCSM-TCL), XXX Peripheral T-cell lymphoma, not otherwise specified (PTCLnos), XXX Nodal lymphomas of follicular T-helper derivation, XXX Angioimmunoblastic T-cell lymphoma (AITL), XXX Follicular T-cell lymphoma (FTCL), XXX Nodal PTCL with follicular T-helper phenotype, XXX Anaplastic large cell lymphoma ALK(+) (ALK(+) ALCL), XXX Anaplastic large cell lymphoma ALK(-) (ALK(-) ALCL), XXX Breast implant-associated anaplastic large cell lymphoma (biaALCL), XXX Neoplastic diseases of histiocytic and dendritic cells, XXX Histiocytic sarcoma (HS), XXX Langerhans cell histiocytosis (LCH), XXX Indeterminate dendritic cell tumor (IDCT), XXX Interdigitating dendritic cell sarcoma (IDCS), XXX Follicular dendritic cell sarcoma (FDCS), XXX Erdheim-Chester disease (EDC), XXX 3 APPENDIX Acute leukemias not recognized by the 2016 WHO classification, XXX Acute leukemia of myeloid/NK precursors (M/NK-AL), XXX Acute leukemia of myeloid dendritic cells (MDCL), XXX Acute leukemia of Langerhans cells, XXX Mature B-cell lymphoblastic leukemia, XXX Composite lymphomas, XXX Hypereosinophilic syndrome (HES), lymphocyte variant, XXX Indolent T lymphoblastic proliferations (iT-LBP), XXX Polyclonal lymphocytoses of B lymphocytes, XXX Persistent polyclonal B-cell lymphocytosis (PPBL), XXX Persistent polyclonal CD5(+) B-cell lymphocytosis, XXX Persistent polyclonal B-cell lymphocytosis, Japanese (hairy) variant, XXX Polyclonal plasmacytoses, XXX Small round (blue) cell tumors (SR(B)CT), XXX Index